| Acquirer | Target | Price |
|---|---|---|
| ICU Medical Inc. | Pfizer's global infusion therapy business | $1 billion |
| Allergan plc | Worldwide rights to MEDI2070 | $250 million |
| Wolters Kluwer, NV | Emmi Solutions | $170 million |
| WellCare Health Plans Inc. | Care1st Health Plan Arizona Inc. | $157.5 million |
| Accord Healthcare Limited | Actavis Generics assets | $760.4 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
